The BRCA genes do not demonstrate equal penetrance and the lifetime risk of developing epithelial ovarian cancer for women with a BRCA1 or BRCA2 mutation is up to 66% and 27%, respectively. The gene discussed is BRCA2; the disease is ovarian carcinoma.